Why this matters for prediabetes and metabolic health GLP-1 medications serve as valuable tools for preventing diabetes and improving metabolic health
Signs that you should hold include persistent nausea lasting more than seven days after a dose escalation, vomiting more than twice per week, diarrhea requiring dietary modification, or appetite suppression severe enough to prevent adequate protein intake
More serious potential adverse effects include pancreatitis, gallbladder disease (cholelithiasis, cholecystitis), acute kidney injury (especially with dehydration), and increased risk of hypoglycemia when used with insulin or sulfonylureas
Accessed at pmc.ncbi.nlm.nih.gov/articles/PMC11034947
Expect close monitoring: Both isotretinoin and GLP-1 medications require medical follow-up
The pharmacology itself comes from the compound, so the platform choice does not alter how the molecule works